EGR1 and major depressive disorder: This analysis revealed significant (p < 0.05) downregulation in the expression of TOB1, NR4A2, and ADM in MDD-subjects, and a trend (p < 0.1) for downregulation for EGR1, as compared to C subjects (Figure 5).